Literature DB >> 9520414

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells.

A A Hasan1, T Zisman, A H Schmaier.   

Abstract

A kininogen binding protein(s), a putative receptor, was identified on endothelial cells. A 54-kDa protein was isolated by a biotin-high molecular mass kininogen (HK) affinity column that, on aminoterminal sequencing of tryptic digests, was identified as cytokeratin 1. Multiple antibodies directed to cytokeratin 1 reacted with a 54-kDa band on immunoblot of lysates of endothelial cells. On laser scanning confocal microscopy, cytokeratin 1 antigen was found on the surface of endothelial cells. Cytokeratin 1 antigen also was detected on endothelial cell membranes by flow cytometry. Moreover, an antipeptide antibody to a sequence unique to cytokeratin 1 also specifically bound to nonpermeabilized endothelial cells. Biotin-HK specifically bound to cytokeratin only in the presence of Zn2+, and cytokeratin blocked biotin-HK binding to endothelial cells. Further, HK and low molecular mass kininogen, but not factor XII, blocked biotin-HK binding to cytokeratin, and peptides of each cell binding region of HK on domains 3,4, and 5 blocked biotin-HK binding to cytokeratin. gC1qR and soluble urokinase-like plasminogen activator receptor also inhibited biotin-HK binding to cytokeratin. These investigations identify a new function for cytokeratin 1 as a kininogen binding protein. Cytokeratins, members of the family of intermediate filament proteins, may represent a new class of receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520414      PMCID: PMC19884          DOI: 10.1073/pnas.95.7.3615

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Amino acid sequences of mouse and human epidermal type II keratins of Mr 67,000 provide a systematic basis for the structural and functional diversity of the end domains of keratin intermediate filament subunits.

Authors:  P M Steinert; D A Parry; W W Idler; L D Johnson; A C Steven; D R Roop
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

2.  Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein.

Authors:  S L Hong
Journal:  Thromb Res       Date:  1980-06-15       Impact factor: 3.944

3.  Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.

Authors:  E S Barnathan; A Kuo; L Rosenfeld; K Karikó; M Leski; F Robbiati; M L Nolli; J Henkin; D B Cines
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

4.  Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes.

Authors:  M J Wells; M W Hatton; B Hewlett; T J Podor; W P Sheffield; M A Blajchman
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

5.  Receptors for high molecular weight kininogen on stimulated washed human platelets.

Authors:  J S Greengard; J H Griffin
Journal:  Biochemistry       Date:  1984-12-18       Impact factor: 3.162

6.  Tissue plasminogen activator release in vivo in response to vasoactive agents.

Authors:  D Smith; M Gilbert; W G Owen
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

7.  The dynamic phosphorylation of the human intermediate filament keratin 1 chain.

Authors:  P M Steinert
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

8.  Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists.

Authors:  D J Crutchley; J W Ryan; U S Ryan; G H Fisher
Journal:  Biochim Biophys Acta       Date:  1983-03-22

9.  High molecular weight kininogen binds to unstimulated platelets.

Authors:  E J Gustafson; D Schutsky; L C Knight; A H Schmaier
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

10.  Activation of the classical pathway of complement by Hageman factor fragment.

Authors:  B Ghebrehiwet; M Silverberg; A P Kaplan
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  34 in total

Review 1.  The plasma kallikrein-kinin system counterbalances the renin-angiotensin system.

Authors:  Alvin H Schmaier
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.

Authors:  Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-26       Impact factor: 11.205

3.  Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4.

Authors:  Yuta Okamura; Kosuke Otani; Akihiro Sekiguchi; Taisuke Kogane; Chiharu Kakuda; Yuzaburo Sakamoto; Tomoko Kodama; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  Pflugers Arch       Date:  2017-04-13       Impact factor: 3.657

4.  Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system.

Authors:  Joshua M Astern; William F Pendergraft; Ronald J Falk; J Charles Jennette; Alvin H Schmaier; Fakhri Mahdi; Gloria A Preston
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.

Authors:  Danyu Sun; Keith R McCrae
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 6.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

7.  Physiologic activities of the contact activation system.

Authors:  Alvin H Schmaier
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

8.  SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion.

Authors:  Marilena Gallotta; Giovanni Gancitano; Giampiero Pietrocola; Marirosa Mora; Alfredo Pezzicoli; Giovanna Tuscano; Emiliano Chiarot; Vincenzo Nardi-Dei; Anna Rita Taddei; Simonetta Rindi; Pietro Speziale; Marco Soriani; Guido Grandi; Immaculada Margarit; Giuliano Bensi
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  B2 kinin receptor activation is the predominant mechanism by which trypsin mediates endothelium-dependent relaxation in bovine coronary arteries.

Authors:  Grant R Drummond; Stavros Selemidis; Thomas M Cocks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

10.  Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta.

Authors:  Mohammad M Khan; Yuchuan Liu; Munir E Khan; Megan L Gilman; Sabina T Khan; Michael Bromberg; Robert W Colman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.